Join the Head and Neck Cancer group to help and get support from people like you.
Head and Neck Cancer News
Related terms: Oral Cancer
Survivorship Interest, Knowledge Limited in Head and Neck Cancer Survivors
TUESDAY, May 13, 2025 – About one-third of head and neck squamous cell cancer (HNSCC) survivors who have undergone radiation therapy (RT) are interested in, prioritize, and have information related...
Computer-Aided Design and Manufacturing Assists Jaw Reconstruction
FRIDAY, May 9, 2025 – Computer-aided design and manufacturing (CAD/CAM) techniques can improve some key clinical outcomes for patients undergoing jaw reconstruction after surgery for head and neck...
Cancer Patient Avoided Side Effects With New Advance In Radiation Therapy
TUESDAY, May 6, 2025 — Tiffiney Beard expected a rough road ahead after her April 2024 diagnosis with a rare cancer of the salivary glands. Tumors from adenoid cystic carcinoma target the body’s ner...
Sugar-Sweetened Beverage Intake Increases Oral Cavity Cancer Risk in Women
THURSDAY, March 20, 2025 – High sugar-sweetened beverage (SSB) intake is associated with an increased risk for oral cavity cancer (OCC) in women, according to a study published online March 13 in...
Shifts in Trends Noted for Trachea, Bronchus, Lung Cancer Mortality
WEDNESDAY, Jan. 15, 2025 – Tobacco-associated trachea, bronchus, and lung (TBL) cancer mortality is declining, while ambient particulate matter (PM)-associated TBL cancer mortality is increasing,...
Surgeon General Highlights Link Between Alcohol and Cancer, Urges Warning Labels
MONDAY, Jan. 6, 2025 – In a new Advisory on Alcohol and Cancer Risk, Surgeon General Vivek Murthy connects alcohol consumption to increased cancer risk and calls for updated warning labels on...
FDA Approves Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Subcutaneous Injection for Use in Most Previously Approved Solid Tumor Opdivo (nivolumab) Indications
PRINCETON, N.J.--(BUSINESS WIRE) December 27, 2024 – Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) granted approval for Opdivo Qvantig (nivolumab...
Risk for Head and Neck Cancer Lower for Coffee and Tea Drinkers
MONDAY, Dec. 23, 2024 – Coffee and tea drinkers have a reduced risk for head and neck cancer (HNC), according to research published online Dec. 23 in Cancer. Timothy Nguyen, M.P.H., from the...
Many Lack Knowledge of Link Between HPV and Oropharyngeal Cancer
TUESDAY, Dec. 17, 2024 – Knowledge of the association between human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma (OPSCC) is poor and did not improve from 2018 to 2020, according to...
Radiotherapy With Adjuvant Durvalumab No Benefit for Head, Neck Cancer
MONDAY, Dec. 9, 2024 – For patients with locoregionally advanced head and neck squamous cell carcinoma (HNSCC) with a contraindication for cisplatin, radiotherapy with adjuvant durvalumab does not...
There's a Best Option for Patients With Head-and-Neck Cancer Who Can't Take Cisplatin
TUESDAY, Nov. 26, 2024 – Cisplatin is the go-to chemotherapy for people battling head-and-neck cancers, but nearly a third of patients can't tolerate its side effects and quit the drug. A new trial...
Fine Particulate Matter Linked to Increased Incidence of Head, Neck Cancer
THURSDAY, Nov. 21, 2024 – Exposure to air pollution in the form of particulate matter measuring less than 2.5 µm (PM2.5) is associated with an increased incidence of head and neck cancer, according ...
American Academy of Otolaryngology-Head and Neck Surgery, Sept. 28-Oct. 1
The annual meeting of the American Academy of Otolaryngology-Head and Neck Surgery was held from Sept. 28 to Oct. 1 in Miami, drawing participants from around the world, including otolaryngologists,...
2023 Cisplatin Shortage Tied to Use of Alternatives for Head, Neck Cancer
TUESDAY, Oct. 1, 2024 – The 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a...
Certain Oral Bacteria Tied to Risk for New Head, Neck Squamous Cell Cancer
WEDNESDAY, Oct. 2, 2024 – Certain oral bacteria are a risk factor for development of head and neck squamous cell cancer (HNSCC), according to a study published online Sept. 26 in JAMA Oncology. ...